Morpholine → (R)-(3-methyl-4-(4-morpholinophthalazin-1-yl)piperazin-1-yl)(phenyl)methanone

HRID 1689971노트

반응식

HRID 1689971 반응식
CC(C)([O-])C.[Na+].C1(P(C2C=CC=CC=2)C2(P(C3C=CC=CC=3)C3C=CC=CC=3)CC=C3C(C=CC=C3)=C2C2C3C(=CC=CC=3)C=CC=2)C=CC=CC=1.Cl[C:54]1[C:63]2[C:58](=[CH:59][CH:60]=[CH:61][CH:62]=2)[C:57]([N:64]2[CH2:69][CH2:68][N:67]([C:70]([C:72]3[CH:77]=[CH:76][CH:75]=[CH:74][CH:73]=3)=[O:71])[CH2:66][C@H:65]2[CH3:78])=[N:56][N:55]=1.[NH:79]1[CH2:84][CH2:83][O:82][CH2:81][CH2:80]1>ClCCl.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd]>[CH3:78][C@H:65]1[N:64]([C:57]2[C:58]3[C:63](=[CH:62][CH:61]=[CH:60][CH:59]=3)[C:54]([N:79]3[CH2:84][CH2:83][O:82][CH2:81][CH2:80]3)=[N:55][N:56]=2)[CH2:69][CH2:68][N:67]([C:70]([C:72]2[CH:77]=[CH:76][CH:75]=[CH:74][CH:73]=2)=[O:71])[CH2:66]1

참가 물질

7

반응 조건

온도
80 °C

실험 절차

Compound 66 was prepared as described in general method E. Sodium t-butoxide (0.0550 g, 0.572 mmol), rac-2,2-bis(diphenylphosphino)-1,1-binaphthalene (0.0102 g, 0.0164 mmol), tris(dibenzylideneacetone)dipalladium (0) (0.00749 g, 0.00818 mmol), and (R)-(4-(4-chlorophthalazin-1-yl)-3-methylpiperazin-1-yl)(phenyl)methanone JK-5 (0.150 g, 0.409 mmol) were combined in a screw cap vial, purged to argon, and solvated with degassed morpholine (0.142 mL, 1.64 mmol). The reaction vial was sealed and stirred at 80° C. After 16 h, the reaction was taken up in dichloromethane and directly loaded onto silica gel. Purification by column chromatography (gradient elution 40 to 100% ethyl acetate in hexanes) afforded 66. MS (M+H)+=418.1.

후처리

  1. customCompound 66 was prepared
  2. customcap vial
  3. custompurged to argon
  4. customThe reaction
  5. customvial was sealed
  6. customPurification
  7. washby column chromatography (gradient elution 40 to 100% ethyl acetate in hexanes)

출처 및 근거

ORD 기록
ord-fe40f602191d402fafc846fd49d0d13a
출처 데이터셋
uspto-grants-2012_04
특허 번호
US08153633B2

반응 노트

불러오는 중…